| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Bone morphogenetic protein receptor type-1A [198-525] |
|---|
| Ligand | BDBM522134 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Luminescence-Based ADPGlo Kinase Activity Assay |
|---|
| IC50 | 3400±n/a nM |
|---|
| Citation |  Arista, L; Chamoin, S; D''Alessandro, PL; Lindvall, M; Lizos, D; Stiefl, NJ; Teixeira-Fouchard, S; Ullrich, T; Weiler, S Pyridinone derivatives and their use as selective ALK-2 inhibitors US Patent US11160797 Publication Date 11/2/2021 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Bone morphogenetic protein receptor type-1A [198-525] |
|---|
| Name: | Bone morphogenetic protein receptor type-1A [198-525] |
|---|
| Synonyms: | ACVRLK3 | ALK3 | Activin receptor-like kinase 3 (ALK3) (aa 198-525) | Activin receptor-like kinase 3 (ALK3)(198-525) | BMPR1A | BMR1A_HUMAN |
|---|
| Type: | Enzyme Catalytic Domain |
|---|
| Mol. Mass.: | 37140.17 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | aa 198-525 |
|---|
| Residue: | 328 |
|---|
| Sequence: | AFIPVGESLKDLIDQSQSSGSGSGLPLLVQRTIAKQIQMVRQVGKGRYGEVWMGKWRGEK
VAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL
YDFLKCATLDTRALLKLAYSAACGLCHLHTEIYGTQGKPAIAHRDLKSKNILIKKNGSCC
IADLGLAVKFNSDTNEVDVPLNTRVGTKRYMAPEVLDESLNKNHFQPYIMADIYSFGLII
WEMARRCITGGIVEEYQLPYYNMVPSDPSYEDMREVVCVKRLRPIVSNRWNSDECLRAVL
KLMSECWAHNPASRLTALRIKKTLAKMV
|
|
|
|---|
| BDBM522134 |
|---|
| n/a |
|---|
| Name | BDBM522134 |
|---|
| Synonyms: | US11160797, Example 42 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C22H22N4O2 |
|---|
| Mol. Mass. | 374.4357 |
|---|
| SMILES | CC(C)n1cc(ccc1=O)-c1cc(cnc1N)-c1ccc2N(C)C(=O)Cc2c1 |
|---|
| Structure | 
|
|---|
Search and Browse
